Roger Jeffs - Mar 14, 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
Stock symbol
AXSM
Transactions as of
Mar 14, 2024
Transactions value $
-$1,467,463
Form type
4
Date filed
3/15/2024, 08:05 PM
Previous filing
Feb 29, 2024
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $286K +13K +10.77% $22.03 134K Mar 14, 2024 Direct F1, F2
transaction AXSM Common Stock Sale -$906K -13K -9.72% $69.70 121K Mar 14, 2024 Direct F2, F3
transaction AXSM Common Stock Options Exercise $433K +17K +14.06% $25.53 138K Mar 14, 2024 Direct F1, F2
transaction AXSM Common Stock Sale -$1.18M -17K -12.33% $69.70 121K Mar 14, 2024 Direct F2, F3
transaction AXSM Common Stock Options Exercise $70.2K +2.35K +1.94% $29.91 123K Mar 15, 2024 Direct F1, F2
transaction AXSM Common Stock Sale -$168K -2.35K -1.91% $71.61 121K Mar 15, 2024 Direct F2, F3
holding AXSM Common Stock 46.9K Mar 14, 2024 GRAT F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -13K -100% $0.00* 0 Mar 14, 2024 Common Stock 13K $22.03 Direct F1, F2
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -17K -100% $0.00* 0 Mar 14, 2024 Common Stock 17K $25.53 Direct F1, F2
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -2.35K -100% $0.00* 0 Mar 15, 2024 Common Stock 2.35K $29.91 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options.
F2 Such transaction was pursuant to a pre-approved 10b5-1 plan.
F3 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F4 Represents additional shares held indirectly by the Reporting Person prior to March 14, 2023.